Recently, immunotherapy agents have been suggested for cervical carcinomas, such as anti-CTLA-4, anti-PD-1, anti-PD-L1, anti-VEGF, and anti-EGFR agents. The gene discussed is CTLA4; the disease is cervical carcinoma.